Other functions - cancer prevention agent development program: early phase clinical research

Ended Awarded Last action

Contract number
HHSN261201200033I
Awardee
Awarding agency
Task orders
14 $11,611,307 obligated

Award facts

Opportunity
Combined order value
  • $11,643,443 Current, with exercised options
  • $12,566,317 Potential, with all options
Last date to order 100% complete
IDV ceiling 14% used
$85,000,000.00
Award type
Multiple award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 8 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)

Award details come from SAM.gov/FPDS.

Task orders

Task order Ordering agency Obligated Awarded
Cancer prevention agent development program: early phase clinical research 75N91019F00129 National Cancer Institute (NIH) $2,453,803
A phase i open label, dose escalation clinical trial assessing the safety, tolerability, and feasibility of… HHSN26100013 National Cancer Institute (NIH) $0
Pilot study of daily exemestane in women with complex atypical hyperplasia of the endometrium/endometrial… HHSN26100011 National Cancer Institute (NIH) $1,219,744
A phase i trial of the safety and immunogenicity of RG1-VLP, a candidate broadly protective vaccine for the… HHSN26100012 National Cancer Institute (NIH) $0
R & d- medical: biomedical (applied research/exploratory development) HHSN26100010 National Cancer Institute (NIH) $386,736
Phase IB 9CUAB30 in early stage breast cancer to evaluate biologic effect HHSN26100009 National Cancer Institute (NIH) $566,601
Core infrastructure support HHSN26100008 National Cancer Institute (NIH) $3,223,553
A randomized, double-blind, phase i dose-escalation study of the novel retinoid 9CUAB30 HHSN26100007 National Cancer Institute (NIH) $261,352
R & d-a phase i trial of the safety and immunogenicity of a DNA plasmid based vaccine (wokvac) encoding epitopes… HHSN26100006 National Cancer Institute (NIH) $1,214,305
Core infrastructure support HHSN26100005 National Cancer Institute (NIH) $709,235
A phase II exploratory, randomized, placebo-controlled trial of pomegranate fruit extract (PFE)/pomx in subjects with… HHSN26100003 National Cancer Institute (NIH) $572,545
Torfp l - core infrastructure support HHSN26100004 National Cancer Institute (NIH) $275,765
Phase IIA cancer chemoprevention biomarker study of intermittent erlotinib in subjects with bladder cancer… HHSN26100002 National Cancer Institute (NIH) $559,231
Other functions: cancer prevention agent development program: early phase clinical research - core infrastructure… HHSN26100001 National Cancer Institute (NIH) $168,438
Show all 14

Transactions

Action Obligated Date
Other Administrative Action P00006 $0
Other Administrative Action P00005 $0
Exercise an Option 4 $0
Exercise an Option 3 · Cancer prevention agent development program: early phase clinical research $0
Other Administrative Action 2 $0
Change Order 1 · Cancer prevention agent development program: early phase clinical research $0
Original award $0

Quick answers

Who was awarded contract HHSN261201200033I?

HHSN261201200033I was awarded to University Of Wisconsin System by National Cancer Institute (National Institutes of Health) on September 24, 2012.

How much is contract HHSN261201200033I worth?

Orders under HHSN261201200033I have obligated $11,611,307. Their combined current value, with exercised options, is $11,643,443. Their combined potential value, with all options, is $12,566,317. HHSN261201200033I's own ceiling is $85,000,000.

How many orders have been placed under contract HHSN261201200033I?

14 orders have been placed under HHSN261201200033I, the latest on September 10, 2019.

Who can order from contract HHSN261201200033I?

HHSN261201200033I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract HHSN261201200033I part of a contract vehicle?

Yes. HHSN261201200033I is part of Cancer Prevention Agent Development Program 2012-2017.

Was contract HHSN261201200033I competed?

The extent of competition for HHSN261201200033I was full and open competition. The government received 8 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV